Copyright
©The Author(s) 2022.
Artif Intell Med Imaging. Apr 28, 2022; 3(2): 21-32
Published online Apr 28, 2022. doi: 10.35711/aimi.v3.i2.21
Published online Apr 28, 2022. doi: 10.35711/aimi.v3.i2.21
Ref. | Clinical question | Training set (number of subjects) | Validation set (number of subjects) | AI instrument | AUROC | Accuracy | Sensitivity | Specificity | |
Udristoiu et al[84], 2021 | Detecting focal pancreatic masses in four EUS imaging modalities | 65 | CNN and Long Short-term Memory models | 0.97 | 97.6% | 98.1% | 96.7% | ||
Tonozuka et al[83], 2021 | Detecting PDAC in patients with normal pancreas/Chronic pancreatitis | 92 | CNN | 0.924 | NA | 90.2% | 74.9% | ||
Marya et al[78], 2021 | Differentiate AIP from PDAC, chronic pancreatitis and other pancreatic diseases | 336 | 124 | CNN | 0.976 | NA | 95% | 90% | |
Kuwahara et al[77], 2019 | Predicting malignancy in IPMN | 50 | CNN | 0.98 | 94% | 95.7% | 92.6% | ||
Ozkan et al[80], 2016 | Differentiating pancreatic cancer from healthy pancreas | 260 images | 72 images | ANN | NA | 87.5% | 83.3% | 93.3% | |
Saftoiu et al[81], 2015 | Differentiate pancreatic cancer from chronic pancreatitis | 117 | 25 | ANN | NA | NA | 94.6% | 94.4% | |
Zhu et al[86], 2013 | Differentiating pancreatic cancer from chronic pancreatitis. | 194 | 194 | SVM | NA | 94.2% | 96.3% | 93.4% | |
Saftoiu et al[82], 2012 | Diagnosis of focal pancreatic lesions | 258 patients | ANN | 0.94 | 84.27% | 87.59% | 82.94% | ||
Zhang et al[85], 2010 | Differentiate pancreatic cancer from non-tumorous tissue | 108 | 108 | SVM | NA | 97.98% | 94.3% | 99.45% | |
Saftoiu et al[20], 2008 cancer | Differentiate normal pancreas, chronic pancreatitis, pancreatic cancer, and neuroendocrine tumors | 68 | Neural network | 0.847 (for PDAC vs chronic pan-creatitis) | 86.1% (for PDAC vs chronic pan-creatitis) | 93.8% (for PDAC vs chronic pan-creatitis) | 63.6% (for PDAC vs chronic pan-creatitis) | ||
Das et al[19], 2008 | Differentiating pancreatic adenocarcinoma from non-neoplastic tissue (includes normal pancreas and chronic pancreatitis) | 160 | 159 | ANN | 0.93 | NA | 93% | 92% | |
Norton et al[79], 2001 | Differentiate malignancy from pancreatitis | 35 | ML | NA | 80% | 100% | 50% |
- Citation: Lin KW, Ang TL, Li JW. Role of artificial intelligence in early detection and screening for pancreatic adenocarcinoma. Artif Intell Med Imaging 2022; 3(2): 21-32
- URL: https://www.wjgnet.com/2644-3260/full/v3/i2/21.htm
- DOI: https://dx.doi.org/10.35711/aimi.v3.i2.21